ClinicalTrials.Veeva

Menu

Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety

M

Michael J. Zvolensky, Ph.D.

Status

Enrolling

Conditions

Alcohol Abuse
Anxiety

Treatments

Behavioral: Aliento

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05288699
STUDY00003577

Details and patient eligibility

About

The purpose of this study is to develop and examine a culturally adapted, brief, integrated, Spanish language mobile health application for the Android platform, optimized to deliver a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Latinx hazardous drinkers with clinical anxiety.

Full description

Investigators will develop a culturally adapted, brief, single-session, Spanish language, PFI delivered via a mobile health application for the Android platform through an iterative approach using expert input and focus groups. Next, Latinx hazardous drinkers with clinical anxiety will assess program navigation and conduct usability testing. Finally, Latinx hazardous drinkers with clinical anxiety will be recruited to complete the final prototype of the mobile health application in order to evaluate the feasibility, acceptability, and initial effects. Initial screening will be conducted via telephone; baseline and post-treatment data will be collected in-person; and 1-week, 1-month, and 3-months follow-up data will be collected remotely.

Enrollment

50 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 21 years of age or older
  • self-identified as Latinx or Hispanic
  • fluent in Spanish
  • current hazardous drinking pattern
  • current clinical anxiety
  • able to provide written, informed consent
  • owning an Android smartphone

Exclusion criteria

  • currently involved in alcohol or other substance use program
  • concurrent use of medication for anxiety or depression
  • current engagement in psychotherapy for anxiety or depression

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Aliento
Experimental group
Description:
Participants complete the brief (\~30 minute) intervention at baseline and will have access to intervention material for up to 3-months after the baseline appointment via the mobile health application.
Treatment:
Behavioral: Aliento

Trial contacts and locations

1

Loading...

Central trial contact

Brooke Y Kauffman, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems